erythrosine has been researched along with Emesis in 13 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The value of administering 25 mg of levosulpiride per os approximately one hour before the sodium fluorescein bolus used in fluorangiography is assessed in order to avoid to the onset of nausea and/or vomiting during and after the test." | 3.68 | [The clinical use of levosulpiride in retinal fluorangiography]. ( Bianchetti, L; Fusi, L; Paneghel, D; Rosina, A; Torrero, M; Vanzetti, M, 1990) |
| "Nausea was most common; vomiting was infrequent, and urticaria rare (1." | 1.26 | Adverse reaction to intravenous fluorescein: evidence for sex difference. ( Bell, LW; Greene, GS; Hitching, RA; Spaeth, GL, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (69.23) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, G | 1 |
| Butner, RW | 1 |
| McPherson, AR | 1 |
| Coscas, G | 1 |
| Binaghi, M | 1 |
| Quentel, G | 1 |
| Jennings, BJ | 1 |
| Mathews, DE | 1 |
| McLauchlan, R | 1 |
| Waterman, H | 1 |
| Waterman, C | 1 |
| Hillier, V | 1 |
| Dodd, C | 1 |
| Greene, GS | 1 |
| Bell, LW | 1 |
| Hitching, RA | 1 |
| Spaeth, GL | 1 |
| Kwiterovich, KA | 1 |
| Maguire, MG | 1 |
| Murphy, RP | 1 |
| Schachat, AP | 1 |
| Bressler, NM | 1 |
| Bressler, SB | 1 |
| Fine, SL | 1 |
| Torrero, M | 1 |
| Rosina, A | 1 |
| Paneghel, D | 1 |
| Bianchetti, L | 1 |
| Fusi, L | 1 |
| Vanzetti, M | 1 |
| Lipson, BK | 1 |
| Yannuzzi, LA | 3 |
| Rohrer, KT | 1 |
| Tindel, LJ | 1 |
| Sobel, RS | 1 |
| Costanza, MA | 1 |
| Shields, W | 1 |
| Zang, E | 1 |
| McDonald, WI | 1 |
| Sanders, MD | 1 |
| Justice, J | 1 |
| Baldwin, HA | 1 |
| Hayreh, SS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Microvascular Changes in the Perifoveal Vascular Network Using Optical Coherence Tomography Angiography (OCT-A) in Type I Diabetes Mellitus[NCT03422965] | 600 participants (Actual) | Interventional | 2017-05-08 | Active, not recruiting | |||
| Macular Perfusion Changes in Proliferative Diabetic Retinopathy Following Anti-VEGF Therapy Versus Targeted and Pan-retinal Photocoagulation Using Optical Coherence Tomography Angiography[NCT04674254] | Phase 4 | 43 participants (Actual) | Interventional | 2021-03-30 | Active, not recruiting | ||
| Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography[NCT03246152] | Phase 4 | 31 participants (Actual) | Interventional | 2017-10-23 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Correlation of BCVA change with degree of capillary non-perfusion before and after injections (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | Logmar (Mean) |
|---|---|
| Bevacizumab Group | -0.21 |
Effect of repeated intravitreal Anti-VEGF injections on Foveal Avascular Zone (FAZ) area measured using the freehand tool of ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | mm^2 (Mean) |
|---|---|
| Bevacizumab Group | 0.03 |
Effect of repeated intravitreal Anti-VEGF injections on macular capillary density using the change in the skeletonized vascular density and fractal dimension measured by ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | percentage of vascularity (Mean) |
|---|---|
| Bevacizumab Group | -2.5 |
4 reviews available for erythrosine and Emesis
| Article | Year |
|---|---|
[Incidents and accidents in fluorescence angiography].
Topics: Brain Diseases; Cardiomyopathies; Fluorescein Angiography; Fluoresceins; Humans; Hypersensitivity; N | 1982 |
Complications of intravenous fluorescein injections.
Topics: Cardiovascular Diseases; Drug Eruptions; Emergency Medical Services; Extravasation of Diagnostic and | 1989 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Fluorescein angiography complication survey.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Health Surveys; Heart Diseases; Humans; Nausea; | 1986 |
Recent advances in fluorescein fundus angiography.
Topics: Animals; Blood Flow Velocity; Choroid; Choroid Neoplasms; Edema; Fluorescein Angiography; Fluorescei | 1974 |
1 trial available for erythrosine and Emesis
| Article | Year |
|---|---|
Effective differences in the formulation of intravenous fluorescein and related side effects.
Topics: Bicarbonates; Chromatography, Thin Layer; Clinical Trials as Topic; Drug Hypersensitivity; Fluoresce | 1974 |
8 other studies available for erythrosine and Emesis
| Article | Year |
|---|---|
[Complications of fundus fluorescein angiography].
Topics: Adolescent; Adult; Aged; Child; Drug Hypersensitivity; Female; Fluorescein Angiography; Fluoresceins | 1983 |
Adverse reactions in intravenous fluorescein angiography.
Topics: Female; Fluorescein Angiography; Fluoresceins; Humans; Male; Nausea; Pruritus; Urticaria; Vomiting | 1983 |
Adverse reactions during retinal fluorescein angiography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anaphylaxis; Child; Drug Hypersensitivity; Female; Fluor | 1994 |
Ethnic variation in fluorescein angiography induced nausea and vomiting.
Topics: Adult; Aged; Aged, 80 and over; Anxiety; England; Eye Diseases; Female; Fluorescein Angiography; Flu | 2001 |
Adverse reaction to intravenous fluorescein: evidence for sex difference.
Topics: Female; Fluorescein Angiography; Fluoresceins; Humans; Injections, Intravenous; Male; Nausea; Prurit | 1976 |
Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study.
Topics: Fluorescein; Fluorescein Angiography; Fluoresceins; Humans; Injections, Intravenous; Nausea; Prospec | 1991 |
[The clinical use of levosulpiride in retinal fluorangiography].
Topics: Adult; Aged; Fluorescein; Fluorescein Angiography; Fluoresceins; Humans; Middle Aged; Nausea; Radiog | 1990 |
Migraine complicated by ischaemic papillopathy.
Topics: Angiography; Carotid Arteries; Eye; Eye Diseases; Female; Fluoresceins; Fundus Oculi; Humans; Ischem | 1971 |